Back to Search Start Over

Why is it hard to terminate failing projects in pharmaceutical R&D?

Authors :
Richard Peck
Dennis Lendrem
Iain Grant
B. Clare Lendrem
John D. Isaacs
Source :
Nature Reviews Drug Discovery. 14:663-664
Publication Year :
2015
Publisher :
Springer Science and Business Media LLC, 2015.

Abstract

'Quick-kill' strategies in pharmaceutical research and development aim to reduce late-stage attrition by bringing project termination decisions forward, to an earlier point in the process. How can the barriers to implementing such strategies be overcome?

Subjects

Subjects :
Pharmacology
Drug Industry
Risk analysis (engineering)
Process (engineering)
Research
Drug Discovery
medicine
Humans
Attrition
General Medicine
Business
medicine.disease
Drug industry

Details

ISSN :
14741784 and 14741776
Volume :
14
Database :
OpenAIRE
Journal :
Nature Reviews Drug Discovery
Accession number :
edsair.doi.dedup.....956154fcfaa313d6fa46d43856dfd115
Full Text :
https://doi.org/10.1038/nrd4725
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details